RIPK3 and neoplasm: Bozec et al. found that CRC model mice in the presence of RIPK3 deletion were more likely to exhibit higher levels of heterotopic hyperplasia and progress to highly differentiated intramucosal adenocarcinomas, promoting tumor formation (Bozec et al., 2016).